- AU$6.68m
- AU$5.72m
- AU$7.82m
- 47
- 48
- 16
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.77 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -1358.97% | ||
| Operating Margin | -70.12% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 5.52 | 6.26 | 7.03 | 6.54 | 7.82 | n/a | n/a | 8.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Global Health Limited is an Australia-based company that provides digital health solutions to the Australian Healthcare Industry. The Company helps the delivery of healthcare services and provide better health outcomes, and its software targets organizations that provide healthcare services to people living with chronic conditions, such as mental health illness, diabetes, and cardiovascular disease. It offers a range of bespoke software and software-as-a-service (SaaS) solutions helping health businesses to be efficient and deliver patient care. These include electronic medical records for health delivery organizations, client management systems for community health, patient administration systems for hospitals, practice management systems, secure messaging for connected care, patient engagement platforms and consumer health records. The Company's brands include MasterCare, MasterCare+, PrimaryClinic, ReferralNet, HotHealth and Lifecard.
Directors
- Steven Pynt NEC (56)
- Michael Davies CEO
- Ershad Ali CFO
- Islah Ishak GMG
- Mathew Cherian EDR (62)
- Sam Butcher SEC
- Karen Corry NID
- Robert Knowles NID (68)
- Stuart Smith NID (61)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 28th, 2000
- Public Since
- April 4th, 2000
- No. of Shareholders
- 534
- No. of Employees
- 49
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 58,049,535
- Address
- Level 2, 696 Bourke Street, MELBOURNE, 3000
- Web
- https://www.global-health.com/
- Phone
- +61 396750600
- Auditors
- HLB Mann Judd
Upcoming Events for GLH
Similar to GLH
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Global Health share price?
As of Today at 19:09 UTC, shares in Global Health are trading at AU$0.12. This share price information is delayed by 15 minutes.
How has the Global Health share price performed this year?
Shares in Global Health last closed at AU$0.12 and the price had moved by -42.5% over the past 365 days. In terms of relative price strength the Global Health share price has underperformed the ASX All Ordinaries Index by -45% over the past year.
What are the analyst and broker recommendations for Global Health?
There is no consensus recommendation for this security.
What is the Global Health dividend yield?
Global Health does not currently pay a dividend.
Does Global Health pay a dividend?
Global Health does not currently pay a dividend.
When does Global Health next pay dividends?
Global Health does not currently pay a dividend.
How do I buy Global Health shares?
To buy shares in Global Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Global Health?
As of the previous close price of AU$0.12, shares in Global Health had a market capitalisation of AU$6.68m.
Where are Global Health shares listed?
Here are the trading details for Global Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: GLH
What kind of share is Global Health?
Based on an overall assessment of its quality, value and momentum Global Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Global Health share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Global Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -31.77%.
As of the last closing price of AU$0.12, shares in Global Health were trading -29.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Global Health PE Ratio?
The Global Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Global Health?
Global Health's management team is headed by:
- Steven Pynt - NEC
- Michael Davies - CEO
- Ershad Ali - CFO
- Islah Ishak - GMG
- Mathew Cherian - EDR
- Sam Butcher - SEC
- Karen Corry - NID
- Robert Knowles - NID
- Stuart Smith - NID